2023 ASM Program

ANZSN Annual Scientific Meeting Provisional Program

4th – 6th September 2023

Please note this is a provisional program and subject to change as the program is confirmed. Please check this page regularly for any updates.

The 2023 ANZSN ASM and Auxiliary Events will be held at Te Pae Convention Centre, Christchurch.

[print-me target=”.gt-site-inner” class=”print-me”]

[bws_pdfprint class=”pdfprint”]

Rāhina, 4 Mahuru, 2023 | MONDAY 4 September 2023

0800 – 0830	Whakawhanaungatanga \| Registration & Networking \| Exhibition Hall E3
PLENARY #1 \| Auditorium 1 \| Chair: David Johnson
0830 – 0837	Mihi whakatau – Ngāi Tūāhuriri
0837 – 0900	Rāhiri Timuaki \| President’s Welcome
0900 – 1000	Kaikōrero matua \| Plenary Speaker Martina Kamaka UTILISING AN INDIGENOUS KNOWLEDGE LENS TO ADDRESS HEALTH EQUITY (followed by He patai \| Q&A)
1000 – 1030	Kai and kōrero \| Morning Tea in the Exhibition \| Exhibition Hall E3
1030 – 1200	CONCURRENT SESSION #1
	Hui taumata \| Symposium	Hui taumata \| Symposium	Whakaatu ā-waha \| Mini Orals	Whakaatu ā-waha \| Mini Orals
Themes	Discovery and Translational Science Auditorium 1	Consumer Workshop for Nephrologists Conway Rooms 1 & 2	General Nephrology – Epidemiology and Public Health / Other Conway Rooms 3 & 4	Nutrition / Peritoneal Dialysis / Quality Indicators Conway Room 5
Chairs	Ana Nunez Nescolarde & Jay Jha	Brooke Huuskes, Traci Stanbury & Natalie Brown	Solomon Menahem & Sine Donnellan	Katrina Chau & Henry Guo
1030 – 1100	REGULATION OF EPITHELIAL SODIUM CHANNELS BY EXTERNAL CUES Thomas Kleyman	KIA KOTAHI PARTNERSHIP IN DESIGN – TE TIRITI INFLUENCED CO-DESIGN FOR GENUINE ENGAGEMENT Ngaire Button (Ngati Porou, Ngai Tuhoe), Koral Fitzgerald (Tangata Tiriti), Brooke Kaminski (Ngāti Raukawa, Ngāti Manipoto) Partnership in design puts people and whānau at the heart for health service design. Its foundations lie in the Canterbury Māori Health Framework and co-design methods. Join us to learn more about how this model is being applied across the district and implications for it’s broader use.	TEMPORAL AND DEMOGRAPHIC TRENDS OF GLOMERULAR DISEASE IN THE GOLD COAST OVER THE PAST 17 YEARS Julian Conboy	THE PREVALENCE AND RISK FACTORS OF SARCOPENIA AMONG PATIENTS RECEIVING DIALYSIS- A SYSTEMATIC REVIEW AND META-ANALYSIS Joanna Stockings
			HOW DO WE KNOW IF WE DO NOT SCREEN? THE TE TAI TOKERAU EARLY CKD PROGRAMME Walaa Saweirs	DIET IN THE MANAGEMENT OF NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (CKD): PERCEPTIONS AND EXPERIENCES OF PATIENTS LIVING WITH RENAL DISEASE Stephanie Notaras
			GEOGRAPHIC VARIATIONS IN THE EPIDEMIOLOGY OF KIDNEY FAILURE IN AOTEAROA NEW ZEALAND Johanna Birrell	CAREGIVERS: AN UNTAPPED RESOURCE TO IMPROVE PERSON-CENTERED DIETARY CARE OF PEOPLE WITH CHRONIC KIDNEY DISEASE? Georgina Lockwood
			PRE-OPERATIVE KIDNEY DISEASE & POST-OPERATIVE MORTALITY FOR CORONARY ARTERY BYPASS GRAFTING IN AUSTRALIA 2001-2019 Dominic Keuskamp	CAN TELEHEALTH IMPROVE ACCESS TO DIETARY MANAGEMENT IN KIDNEY FAILURE? INSIGHTS FROM FOCUS GROUPS WITH CONSUMERS Joanne Beer
1100 – 1130	INNATE IMMUNITY-DRIVEN INFLAMMATION IN CARDIORENAL SYNDROME Thimoteus Speer		ABSOLUTE AND RELATIVE MORTALITY IN PEOPLE RECEIVING DIALYSIS ACROSS FOUR DECADES IN AUSTRALIA, NEW ZEALAND AND THE USA Neeru Agarwal	HAVE BANANAS BEEN WRONGLY ACCUSED? A REVIEW OF DIETARY POTASSIUM AND HYPERKALAEMIA IN CHRONIC KIDNEY DISEASE Erynn McAuley
			RISK FACTORS ASSOCIATED WITH 30-DAY MORTALITY FOLLOWING COVID-19 INFECTION IN AUSTRALIAN AND NEW ZEALAND PATIENTS ON KIDNEY REPLACEMENT THERAPY Peter Kolovos	CARDIAC SURGERY OUTCOMES IN HAEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS OVER 10 YEARS: A SINGLE UNIT STUDY IN WAIKATO HOSPITAL, AOTEAROA NEW ZEALAND Kurinji Nalankilli
			CHARACTERISTICS AND CLINICAL OUTCOMES OF PEOPLE WITH KIDNEY FAILURE OF UNKNOWN AETIOLOGY FROM ANZDATA REGISTRY Lucy Shu Wang	OUTCOMES OF URGENT, EARLY AND CONVENTIONAL START PERITONEAL DIALYSIS IN INCIDENT DIALYSIS PATIENTS George Tsihlis
			PAGE KIDNEY: A RARE PRESENTATION OF RENAL CELL CARCINOMA Sanjana Dang	OUTCOMES OF EARLY AND CONVENTIONAL COMMENCEMENT OF PERITONEAL DIALYSIS George Tsihlis
1130 – 1200	DRUG SCREENING FOR POLYCYSTIC KIDNEY DISEASE USING KIDNEY ORGANOIDS Veronika Sander	BAY OF PLENTY RENAL CONSUMER COUNCIL Kaywyn McKenzie & Rick Rapana Why and how the group was formed, some of the ideas they’ve had so far, how clinicians are working with them, and some plans for the future.	IMPROVING THE DIAGNOSIS AND MANAGEMENT OF CHRONIC KIDNEY DISEASE IN PRIMARY CARE: POST-HOC ANALYSIS OF THE CHRONIC DISEASE IMPACT STEPPED WEDGE CLUSTER RANDOMISED TRIAL Vincent Wong	GASTROINTESTINAL ENDSOCPY ASSOCIATED PD PERITONITIS IN AUSTRALIA AND NEW ZEALAND OVER A 15-YEAR PERIOD Dharmenaan Palamuthusingam
			OPIOID ANALGESIC USE AMONG PATIENTS WITH RENAL INSUFFICIENCY: A SYSTEMATIC REVIEW Megan Sands	DIALYSIS WITHDRAWAL: HOW DO OUR PATIENTS DIE? – A RETROSPECTIVE SINGLE-SITE STUDY Rachel David
		BEAT-CKD: CONSUMER IMPACT AND INVOLVEMENT IN RESEARCH Anastasia Hughes & Jasmin Mazis	RATIONALE AND DESIGN OF THE eCONSENT HD: A HYBRID EFFECTIVENESS-IMPLEMENTATION CLINICAL TRIAL EVALUATING VIDEO-ASSISTED ELECTRONIC CONSENT VS STANDARD CONSENT FOR PATIENTS UNDERGOING HAEMODIALYSIS Pedro Franca Gois	AUDITING DATA QUALITY OF ANZDATA CAUSE OF DEATH REPORTING IN DIALYSIS PATIENTS Alia Tun Ismail

1200 – 1300	Kai and kōrero \| Lunch in the Exhibition \| Exhibition Hall E3 ATKN Trial Meeting \| Conway Room 1 & 2 TSANZ deceased donor kidney allocation algorithm consultation \| Conway Room 3 & 4
Tauira Kairangahau PLENARY #2: Young Investigator Award (12 minute presentation & 2 minutes question time & 1 minute change over) \| Auditorium 1 \| Chair: Kim O’Sullivan
DISCOVERY & TRANSLATIONAL SCIENCE
1300 – 1315	CD8+ REGULATORY T CELLS INDUCED BY PEPTIDE VACCINATION AMELIORATES EXPERIMENTAL MEMBRANOUS NEPHROPATHY Edmund Chung
1315 – 1330	CD4+ α3(135-145)-SPECIFIC T CELLS IN HUMAN GOODPASTURE DISEASE ARE ENRICHED FOR TH1 AND TH17 EFFECTORS AND STEM MEMORY T CELLS Kate Robson
1330 – 1345	STATE-OF-THE-ARTERY: DEVELOPING A 3D-PRINTED, PATIENT-SPECIFIC IN VITRO MODEL OF ARTERIOVENOUS FISTULAS TO REPLACE ANIMALS IN ENDOTHELIAL CELL STUDIES Nasir Shah
1345 – 1400	MULTI-OMIC ANALYSIS OF A HUMAN KIDNEY ORGANOID MODEL OF HYPOXIC INJURY AND MALADAPTIVE REPAIR Ana Nunez Nescolarde
CLINICAL SCIENCE
1400 – 1415	HAEMODIALYSIS CATHETER UTILISATION IN NEW ZEALAND: REPORT FROM THE REDUCCTION TRIAL Jayson Catiwa
1415 – 1430	LONG-TERM SAFETY OF HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS Jeffrey Ha
1430 – 1445	CAUSAL RELATIONSHIP BETWEEN KIDNEY FUNCTION AND CANCER RISK: A MENDELIAN RANDOMISATION STUDY Ellen Dobrijevic
1445 – 1500	SHOULD FAILING HAEMODIALYSIS CATHETERS BE REWIRED OR REMOVED AND REPLACED: INSIGHTS FROM THE NATIONAL REDUCCTION TRIAL Ben Lazarus
1500 – 1530	Kai and kōrero \| Afternoon Tea in the Exhibition \| Exhibition Hall E3
1530 – 1700	CONCURRENT SESSION #2
	Hui taumata \| Symposium	Hui taumata \| Symposium	Whakaatu ā-waha \| Mini Orals	Whakaatu ā-waha \| Mini Orals
Themes	yANZSN Auditorium 1	Cardiometabolic Syndrome Conway Rooms 1 & 2	Haemodialysis – CKD-MBD/Anaemia/Adequacy – Vascular Access – Other / Interventional Nephrology / Indigenous Health Advancement Conway Rooms 3 & 4	Transplantation Conway Room 5
Chairs	Adam Steinberg & Kate Richards	Angela Makris	Franziska Pettit & Michael McLucas	Frederiek Heenan-Vos & Helen Eddington
1530 – 1600	Panel Presentation with: Natasha Rogers Nayan Arora (aka Captain Chloride) Brooke Huuskes Elizabeth Stallworthy	GLOBAL DISPARITIES IN GLOMERULAR DISEASE: EPIDEMIOLOGICAL AND CLINICAL FEATURES AND TREATMENT PATTERNS Seung Hyeok Han	THE EFFECT OF INTRAVENOUS IRON SUCROSE ON FGF23 LEVELS IN A GROUP OF PREVALENT HAEMODIALYSIS-DEPENDENT PATIENTS Aruni Malaweera	PLASMA EXCHANGE AND PATIENT ADMINISTERED SUBCUTANEOUS IMMUNOGLOBULIN FOR TREATMENT OF RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS POST-KIDNEY TRANSPLANTATION Zena Barakat
			A CORE OUTCOMES SET FOR TRIALS IN CHRONIC KIDNEY DISEASE: REPORT OF THE STANDARDIZED OUTCOMES IN NEPHROLOGY – CHRONIC KIDNEY DISEASE (SONG-CKD) STAKEHOLDER WORKSHOPS Andrea Matus	A RURAL/REGIONAL YOUNG ADULT KIDNEY AND TRANSPLANT TRANSITION PROGRAM: GROWTH AND OUTCOMES AT 6 YEARS Matthew Jose
			CONSENSUS-BASED PRIORITIES FOR OUTCOMES IN CLINICAL TRIALS INVOLVING ADULTS WITH CHRONIC KIDNEY DISEASE: A MULTINATIONAL DELPHI SURVEY Andrea Matus	SYMPTOM PREVALENCE AND QUALITY OF LIFE IN KIDNEY TRANSPLANT RECIPIENTS COMPARED WITH PATIENTS ON HOME HAEMODIALYSIS: A SINGLE-CENTRE CROSS-SECTIONAL STUDY IN AUSTRALIA Elaine Phua
			PATIENT ACTIVATION IN PEOPLE WITH CHRONIC KIDNEY DISEASE NOT RECEIVING KIDNEY REPLACEMENT THERAPY: A CROSS-SECTIONAL SURVEY Laura Lunardi	GRAFT AND PATIENT SURVIVAL POST RENAL TRANSPLANT AMONGST INDIGENOUS AUSTRALIANS IN THE NORTHERN TERRITORY Farhan Khan
1600 – 1630		CURTAILING CALORIES OR TIME? EXPLORING THE IMPACTS OF CALORIC RESTRICTION AND MEAL TIMING ON GLUCOSE CONTROL Leonie Heilbronn	BONE SCINTIGRAPHY TO DIAGNOSE CALCIPHYLAXIS: A CASE SERIES Daniel Hirsch	AN ANALYSIS OF ARTERIO-VENOUS FISTULA AND NT-PRO BNP AFTER KIDNEY TRANSPLANTATION Chang Chuan Chew
			MATCHING NEPHROLOGY CARE TO THE NEEDS OF VULNERABLE PATIENTS: ASSESSING FRAILTY IN PATIENTS WITH CHRONIC KIDNEY DISEASE Alice Kennard	DECISION SUPPORT TOOL FOR ASSESSING ABSOLUTE RISK OF CANCER TRANSMISSION FROM DECEASED KIDNEY DONORS Angela Webster
			UNDERSTANDING THE LIVED EXPERIENCE OF FRAILTY AND PATIENT PREFERENCES FOR REHABILITATION IN THE CHRONIC KIDNEY DISEASE CONTEXT: A QUALITATIVE STUDY Alice Kennard	PHYSICIAN AND PATIENT KNOWLEDGE AND ATTITUDES TOWARDS CONTRACEPTION USE AND COUNSELLING IN FEMALE RENAL TRANSPLANT RECIPIENTS Madeleine Cosgrave
			BREAST CANCER SCREENING, INCIDENCE AND MORTALITY IN WOMEN TREATED WITH MAINTENANCE DIALYSIS: A POPULATION-BASED COHORT STUDY Nida Saleem	NOT ON THE LIST: CLINICIAN-REPORTED REASONS FOR NON-LISTING FOR KIDNEY TRANSPLANTATION Stephen McDonald
1630 – 1700		RECENT PARADIGM SHIFTS IN THE MANAGEMENT OF DIABETES AND ITS COMPLICATIONS Elif Ekinci	ADVANCED RECOVERY ROOM CARE VS STANDARD OF CARE IN LIVING DONOR KIDNEY TRANSPLANTATION: A PILOT RANDOMISED CONTROLLED TRIAL Karthik Venkataraman	EARLY REMDESIVIR FOR VACCINATED KIDNEY TRANSPLANT RECIPIENTS WITH MILD-MODERATE COVID-19 INFECTION Daniel Hirsch
			DOPS (DIRECT OBSERVATION OF PROCEDURAL SKILLS) AND RENAL BIOPSY TRAINING AT LIVERPOOL HOSPITAL Andrea Huang	WITHDRAWN
			THE COMPASS PROJECT: GUIDING KIDNEY CARE THROUGH ABORIGINAL PATIENT NAVIGATORS Kelli Owen & Samantha Bateman	WAITLISTING DYNAMICS FOR KIDNEY TRANSPLANTATION IN AOTEAROA NEW ZEALAND: SUSPENSIONS, TRANSPLANTATION AND DEATHS Nicole De La Mata

1700 – 1800	Hui-a-tau \| AGM
1700 – 1930	Welcome Reception \| Poster Session \| Exhibition Hall E3
1845 – 2030	yANZSN Cocktail Party \| Mr. Brightside Rooftop Bar \| Level 4 / 152 Oxford Terrace, Christchurch 8011

Rātū 5 Mahuru 2023 | TUESDAY 5 September 2023

0730 – 0830	Breakfast Session – cancelled
0800 – 0830	Whakawhanaungatanga \| Registration & Networking \| Exhibition Hall E3
PLENARY #3 \| Auditorium 1 \| Chair: Amanda Dickens
0830 – 0845	Welcome to Day 2
0845 – 0945	Kaikōrero matua \| Plenary Speaker Richard Coward TRANSLATING PODOCYTE BIOLOGY INTO BETTER PATIENT CARE
0945 – 1015	Kai and kōrero \| Morning Tea in the Exhibition \| Exhibition Hall E3
1015 – 1145	CONCURRENT SESSION #3
	Discovery & Translational Science Award Session – Brought to you by Amgen, CSL Seqirus, GSK & Pharmacor	Shaun Summers Clinical Trainee Award Session – Brought to you by Amgen, CSL Seqirus, GSK & Pharmacor	Hui taumata \| Symposium	Whakaatu ā-waha \| Mini Orals
Themes	(12 minute presentation, 2 minutes question time & 1 minute change over) Auditorium 1	(5 minute presentation & 2 minutes question time) Conway Rooms 1 & 2	Indigenous Health Advancement Conway Rooms 3 & 4	General Nephrology – Diabetes/Cardiovascular/Hypertension Conway Room 5
Chairs	Veronika Sander	Sharon Ford	Luke Wilson & Johanna Birrell	Stephen May & Kate Richards
1015 – 1030	THERAPEUTIC POTENTIAL OF RESISTANT STARCH SUPPLEMENTATION TO MANIPULATE THE GUT-KIDNEY AXIS TO REDUCE RENAL INFLAMMATION IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY VASCULITIS Kim Maree O’Sullivan	SCREENING AND MANAGEMENT OF POST-TRANSPLANT OSTEOPOROSIS – A SINGLE CENTRE EXPERIENCE Henry Guo	Panel Presentation with: Martina Kamaka Jaqui Hughes Curtis Walker	PRACTICE PATTERNS IN A SPECIALIST HYPERTENSION CLINIC Arunima Jain
1015 – 1030		IMPACTS AND OUTCOMES OF TRAVELLING INTERSTATE FOR KIDNEY TRANSPLANTATION: 8-YEAR EXPERIENCE FROM THE TOP END OF AUSTRALIA, NORTHERN TERRITORY Thomas Gorgegues		REDOX MODULATING SMALL MOLECULE IMPROVES DIABETIC KIDNEY DISEASE IN THE DB/DB MODEL OF TYPE 2 DIABETES Amelia Fotheringham
1030 – 1045	RENOPROTECTIVE EFFECT OF NOX5 INHIBITION IN DIABETIC KIDNEY DISEASE Jay Jha	MENTAL ILLNESS IN PATIENTS WITH KIDNEY FAILURE IN AOTEAROA NEW ZEALAND: A DESCRIPTIVE ANALYSIS Saiprasad Ravi		ADHERENCE AND LONG-TERM TRENDS IN UPTAKE OF CARDIOPROTECTIVE MEDICATION FOLLOWING AN ACUTE MYOCARDIAL INFARCTION AMONG PEOPLE WITH DIABETES AND CKD – A PROSPECTIVE POPULATION-BASED STUDY Daniel O’Hara
1030 – 1045		UTILITY OF PRE-KIDNEY TRANSPLANT THROMBOPHILIA SCREENING ON PREDICTING POST-TRANSPLANT VENOUS THROMBOEMBOLISM Alastair Weng		ADHERENCE AND PERSISTENCE WITH NOVEL GLUCOSE-LOWERING MEDICATIONS IN SWEDEN Daniel O’Hara
1045 – 1100	A NOVEL HYPOPERFUSION-INDUCED ACUTE KIDNEY INJURY MODEL IN DIABETIC RATS. David Nikolic-Paterson	KIDNEY TRANSPLANT GRAFT OUTCOMES OVER 20 YEARS – IMPROVEMENTS IN GRAFT SURVIVAL DESPITE TRANSPLANTING HIGHER RISK DONOR AND RECIPIENTS Monica Suet Ying Ng		BARRIERS AND FACILITATORS FOR SGLT2i UPTAKE AND IMPLEMENTATION – PERSPECTIVES FROM PATIENTS AND CLINICIANS Daniel O’Hara
1045 – 1100		OUTCOMES OF PERITONEAL DIALYSIS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE IN AUSTRALIA AND NEW ZEALAND Matthew Nguyen		EMPAGLIFLOZIN USE AND THE RISK OF NEPHROLITHIASIS IN PATIENTS WITH TYPE 2 DIABETES Francesca Tang
1100 – 1115	HYPOXIA AND INTERLEUKIN (IL)-1β SYNERGISTICALLY INDUCE CELLULAR SENESCENCE IN HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS (PTEC) Kurt Giuliani	ADMISSION PRE-TRANSPLANT HBA1C AND THE RISK OF DIABETES AND ADVERSE OUTCOMES POST-KIDNEY TRANSPLANTATION Su Jen Chua		TRANSCATHETER AORTIC VALVE IMPLANTATION OUTCOMES IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE – A RETROSPECTIVE REVIEW OF A SINGLE AUSTRALIAN CENTRE’S EXPERIENCE Amy Barnett
1100 – 1115		WHY OUR KIDNEY TRANSPLANTS RECIPIENTS (KTR) WERE NOT FULLY VACCINATED AGAINST COVID-19. HOW CAN WE DO BETTER? Rachel Frederick		DECREASED KIDNEY KLOTHO EXPRESSION SHOWS MARKED SEX DEPENDENCY IN PRECLINICAL ANIMAL MODELS OF CHRONIC KIDNEY DISEASE (CKD) Ashleigh Jacqueline Hicks
1115 – 1130	THROMBOSPONDIN-1 IS A NOVEL TARGET DRIVING TYPE 4 CARDIORENAL SYNDROME. Natasha Rogers			DETERMINANTS OF EFFECTS OF SGLT2I ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL Francesca Tang
1115 – 1130				PYRUVATE KINASE M2 ACTIVATION MAINTAINS MITOCHONDRIAL METABOLISM BY REGULATING THE INTERACTION BETWEEN HIF-1α AND PGC-1α IN DIABETIC KIDNEY DISEASE Young Su Joo
1130 – 1145	DIETARY FIBER PROVIDES PROTECTION AGAINST KIDNEY ISCHEMIA REPERFUSION INJURY THROUGH MODULATION OF THE GUT MICROBIOTA Steve Chadban			YOUTH WITH TYPE 1 DIABETES AT HIGHER RISK OF DEVELOPING DIABETIC KIDNEY DISEASE HAVE ALTERATIONS IN THEIR URINE AND PLASMA METABOLOMIC AND MITOCHONDRIAL DNA PROFILES Mitchell Sullivan
1130 – 1145
1145 – 1300	Kai and kōrero \| Lunch in the Exhibition \| Exhibition Hall E3 ANZPNA AGM \| Conway 3 & 4 BEAT-CKD Management Committee Meeting 12pm to 1pm (Invitation Only) \| Conway 1 & 2 RESOLVE & BEAT-Calci Investigator Meeting 12pm to 1pm (Invitation Only) \| Conway Room 5
PLENARY #4 \| Auditorium 1 \| Chair: Natasha Rogers
1300 – 1400	Kaikōrero matua \| Plenary Speaker Thomas Kleymann NEW INSIGHTS IN THE REGULATION OF POTASSIUM HOMEOSTASIS (followed by He patai \| Q&A)
1400 – 1415	Move between session rooms
1415 – 1515	CONCURRENT SESSION #4
	Whakaatu ā-waha \| Mini Orals	Whakaatu ā-waha \| Mini Orals	Whakaatu ā-waha \| Mini Orals	Whakaatu ā-waha \| Mini Orals
Themes	Environmental Sustainability / Experimental Tubulointerstitial Disease / General Nephrology – Acute Kidney Injury / Quality Indicators Auditorium 1	General Nephrology – Glomerulonephritis / Genetics Conway Rooms 1 & 2	Paediatrics / General Nephrology – Other Conway Rooms 3 & 4	General Nephrology – Other Conway Room 5
Chairs	Brooke Huuskes & Jacqueline Phillips	Edmund Chung & Andrew Mallett	Siah Kim	Alice Kennard & Matthew Anderson
1415 – 1515	EFFECT OF PATIENT- AND CENTRE-LEVEL FACTORS ON NEPHROLOGY QUALITY INDICATORS IN AUSTRALIA AND NEW ZEALAND Adam Steinberg	ECULIZUMAB WAS SAFE AND EFFECTIVE IN THE MANAGEMENT OF TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY IN A HEART TRANSPLANT RECIPIENT WITH CONCURRENT SARS-COV-2 INFECTION – A CASE REPORT Vincent Wong	HOSPITALISATION AND EMERGENCY PRESENTATIONS IN CHILDREN WITH CKD: A DATA LINKAGE STUDY Siah Kim	COMPARING DIRECT BEDSIDE TO IN-LABORATORY INOCULATION OF PERITONEAL DIALYSIS (PD) EFFLUENT INTO BLOOD CULTURE BOTTLES ON CULTURE NEGATIVE PD PERITONITIS RATES IN THE SOUTH WESTERN SYDNEY LOCAL HEALTH DISTRICT (SWSLHD) Lachlan Wiedersehn
	TE HUHI RAUPŌ – FIRST OF ITS KIND Leila Arnold	A CASE OF IGA-DOMINANT INFECTION-RELATED GLOMERULONEPHRITIS (IRGN) Jolene Zhuo Lin Ng, Andrea Huang	LONG-TERM RENAL OUTCOMES OF CHILDREN WITH CANCERS TREATED WITH PLATINUM-BASED CHEMOTHERAPY: A RETROSPECTIVE CHART ANALYSIS James Ward	IDENTIFYING AND INTEGRATING CONSUMER PERSPECTIVES IN CLINICAL PRACTICE GUIDELINES ON THE MANAGEMENT OF KIDNEY STONES Adela Yip
	A UNIQUE AND NOVEL Fc-FUSION I-BODY AD-214 ATTENUATES KIDNEY FIBROSIS THROUGH BLOCKING LEUKOCYTE INFILTRATION Qinghua Cao	INCIDENCE, PREVALENCE AND OUTCOMES OF GLOMERULAR DISEASE USING PROBABILISTIC LINKAGE: AN AUSTRALIAN PROSPECTIVE BASED COHORT STUDY Neeru Agarwal	CLINICAL CHARACTERISTICS OF PAEDIATRIC UROLITHIASIS IN THE NORTHERN TERRITORY OF AUSTRALIA James Ward	CASE REPORT: NON-CIRRHOTIC HYPERAMMONAEMIC ENCEPHALOPATHY DUE TO UREAPLASMA PARVUM PERITONITIS IN A MAINTENANCE HAEMODIALYSIS PATIENT Matthew Jose
	HYDROGEL DELIVERY OF A NOVEL AT2R AGONIST IN AN ApoE-STZ MOUSE MODEL OF TYPE 1 DIABETES Sharon Ricardo	VISUAL GENOMIC REPORTS – AN EXERCISE IN CO-DESIGN AND CO-OPERATION Gráinne Butler	AGE AS A DETERMINATE OF CHOICE OF FIRST LINE INVESTIGATION FOR STEROID RESISTANT NEPHROTIC SYNDROME IN CHILDREN Rebecca James	BONE SCINTIGRAPHY IN THE DIAGNOSIS AND MONITORING OF ISOLATED PULMONARY CALCIPHYLAXIS: A CASE REPORT Daniel Hirsch
	JUN PLAYS BOTH PROTECTIVE AND PATHOLOGIC ROLES IN ACUTE AND CHRONIC KIDNEY DISEASE Sanduni Fernando	GENETIC KIDNEY DISEASE LINKED TO DIFFERENT PATIENT MORTALITY AND GRAFT FAILURE RISKS COMPARED TO OTHER KIDNEY DISEASES ON KIDNEY REPLACEMENT THERAPY Monica Suet Ying Ng	VALIDATION OF PREDICTIVE TOOLS FOR MORTALITY IN OLDER PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE Angela Chou	INTERVENTIONS FOR PREVENTING THE PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE. A COCHRANE SYSTEMATIC REVIEW AND META ANALYSIS Isabelle Kitty Stanley
	PHOTOBIOMODULATION ALLEVIATES FOLIC ACID-INDUCED KIDNEY FIBROSIS THROUGH INHIBITION OF TGF-β1 SIGNALLING PATHWAY AND ALLEVIATION OF OXIDATIVE STRESS Ji Bian	GENOMIC ARCHITECTURE OF CHRONIC KIDNEY DISEASE IN AUSTRALIA’S FIRST PEOPLES Simon Lee	PATIENTS’ PERCEPTIONS OF DIALYSIS INITIATION, PROGNOSIS AND END OF LIFE ISSUES – A SINGLE CENTRE, CROSS SECTIONAL STUDY Hayley Worth	IMPROVING DIVERSE AND EQUITABLE INVOLVEMENT OF CONSUMERS IN CHRONIC KIDNEY DISEASE RESEARCH: WORKSHOP REPORT Rosanna Cazzolli
	ESTABLISHMENT OF A MULTI-FACETED ACUTE KIDNEY INJURY (AKI) SERVICE INVOLVING AN AKI E-ALERT SYSTEM AND CARE BUNDLE Sophy Fan	NOVEL GENETIC MARKERS FOR CHRONIC KIDNEY DISEASE IN A POPULATION OF INDIGENOUS AUSTRALIANS: AN INDIVIDUAL AND MULTIPLE PHENOTYPE GENOME-WIDE ASSOCIATION STUDY Vignesh Arunachalam	EXPERIENCE OF LONELINESS AND SOCIAL ISOLATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND THEIR CAREGIVERS. Amanda Sluiter	VALIDATING A CORE OUTCOME MEASURE FOR PAIN IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE Rosanna Cazzolli
1515 – 1545	Kai and kōrero \| Afternoon Tea in the Exhibition \| Exhibition Hall E3
1545 – 1715	CONCURRENT SESSION #5
	Kidney Health Australia (KHA) Clinical Science Award Session	Hui taumata \| Symposium	Hui taumata \| Symposium	Whakaatu ā-waha \| Mini Orals
Themes	(12 minute presentation & 4 minute questions & 1 minute change over) Auditorium 1	Kidney Supportive Care Conway Rooms 1 & 2	When Kidneys Go Bad Conway Rooms 3 & 4	General Nephrology – Health Services Research Conway Room 5
Chairs	Suetonia Palmer	Mark Brown & Thomas Evans	Prasanti Kotagiri	Angela Webster & Cobi Gredric
1545 – 1600	SEX DIFFERENCES IN CARDIOVASCULAR RISK AND KIDNEY FUNCTION: CREATININE VS CYSTATIN C Nicole De La Mata	INTRODUCTION AND EVIDENCE SUPPORTING COMMUNICATION SKILL IN COMPLEX DECISION MAKING Elizabeth Stallworthy	DICKKOPF-3 A NOVEL KIDNEY STRESS MARKER Thimoteus Speer	WITHDRAWN
1545 – 1600		TO DIALYSE OF NOT TO DIALYSE – EVIDENCE-BASED DECISION MAKING AND COMMUNICATION Kelly Li		UNDERSTANDING WHY PATIENTS WITH ADVANCED KIDNEY DISEASE ARE NOT READY TO ENGAGE IN ADVANCE CARE PLANNING Kathryn Ducharlet
1600 – 1615	IMPACT OF PRECONCEPTION CHRONIC KIDNEY DISEASE ON PREGNANCY OUTCOMES AND POSTPARTUM MATERNAL KIDNEY FUNCTION – A NOVEL ANALYSIS OF LINKED PERINATAL AND PATHOLOGY DATASETS Matthew Jose			IT MATTERS WHERE YOU LIVE: COMMONWEALTH, STATE AND TERRITORY POLICIES FOR ACCESS TO CARE FOR AUSTRALIANS WITH CHRONIC KIDNEY DISEASE AND THEIR CAREGIVERS Javier Recabarren
1600 – 1615				ACKNOWLEDGING AND ADDRESSING SOCIAL DETERMINANTS OF HEALTH IN CHRONIC KIDNEY DISEASE: AN ANALYSIS OF HEALTH POLICY RESPONSES ACROSS AUSTRALIAN JURISDICTIONS Javier Recabarren
1615 – 1630	BALANCED ELECTROLYTE SOLUTIONS VERSUS NORMAL SALINE FOR KIDNEY TRANSPLANTATION: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS Michael Collins		Wei Chen	THE ROLE AND IMPACT OF THE CONSUMER ADVISORY BOARD IN THE STRUCTURED EXERCISE PROGRAM TO REDUCE FATIGUE IN PATIENTS RECEIVING DIALYSIS: AN ADAPTIVE TRIAL (M-FIT) Javier Recabarren
1615 – 1630				DIGITAL HEALTH INTERVENTIONS FOR PHYSICAL ACTIVITY IN CHRONIC KIDNEY DISEASE: SYSTEMATIC REVIEW Thai Binh Tran
1630 – 1645	HOSPITAL MORTALITY FOLLOWING INTENSIVE CARE ADMISSION OF ADULTS WITH KIDNEY DISEASE 2018-2020: AN AUSTRALIAN DATA LINKAGE STUDY Dominic Keuskamp			TELECLINICAL CARE IN CHRONIC KIDNEY DISEASE: ACCEPTABILITY AND INITIAL USER TESTING OF A VIRTUAL EXERCISE DELIVERY PLATFORM Thai Binh Tran
1630 – 1645		DIALYSIS WITHDRAWAL – NAVIGATING CONFLICTS, EMOTIONS, AND LEGAL ASPECTS Frank Brennan, Elizabeth Stallworthy		CHRONIC KIDNEY DISEASE STEWARDSHIP: A HOSPITAL BASED INITIATIVE FOR EARLY REFERRAL TO NEPHROLOGY CARE Lucy Wynter
1645 – 1700	IMPROVEMENTS IN ACCESS TO KIDNEY TRANSPLANTATION FOR ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE Stephen McDonald		CARDIORENAL SYNDROME: CHANGING THE PARADIGM Nayan Arora	“A WIN-WIN SITUATION”: PERSPECTIVES OF PATIENT AND FAMILY INVOLVEMENT IN THE 2022 KIDGEN SYMPOSIUM Hugh McCarthy
1645 – 1700				VALUES , PREFERENCES, AND RISK TOLERANCE OF PEOPLE WAITLISTED FOR KIDNEY TRANSPLANT: A SYSTEMATIC REVIEW Rachel Cutting
1700 – 1715	BURDEN OF HAEMODIALYSIS CATHETER-RELATED BLOODSTREAM INFECTIONS IN AUSTRALIA: A NATIONAL DATA-LINKAGE STUDY Ben Lazarus			A SYSTEMATIC DELPHI PRIORITISATION PROCESS ON SYNTHESISED EVIDENCE INFORMING CLINICAL CARE IN PERITONEAL DIALYSIS Brydee Cashmore
1700 – 1715		Group Q&A
1900 till Late	Gala Dinner brought to you by Amgen \| Rakaia Room \| Te Pae

Rāapa 6 Mahuru 2023 | WEDNESDAY 6 September 2023

0730 – 0830	Breakfast Session (GSK) \| Conway 3 & 4 “It’s not just COVID” Status of respiratory virus epidemiology and management post the pandemic! A/Prof Michael D Nissen
0800 – 0915	Whakawhanaungatanga \| Registration & Networking \| Exhibition Hall E3
0915 – 1045	CONCURRENT SESSION #6
	Hui taumata \| Symposium	Hui taumata \| Symposium	Hui taumata \| Symposium	Hui taumata \| Symposium
Themes	ANZDATA Auditorium 1	ANZPNA Conway Rooms 1 & 2	Environmental Sustainability Conway Rooms 3 & 4	New Approaches to Transplantation Conway Room 5
Chairs	Drew Hendeson	Hugh McCarthy & Rachael Kermond	Paul Lawton	Matthew Rowlandson
0915 – 0930	ANZDATA OVERVIEW Nick Gray	GENETIC AND MOLECULAR APPROACHES TO DIAGNOSE AND TREAT CHILDREN WITH KIDNEY DISEASE Richard Coward	CLIMATE CHANGE IMPACTS, ADAPTATION AND VULNERABILITY: WHAT DOES THE 2023 IPCC SYNTHESIS REPORT SAY? Bronwyn Hayward	EXPLORING ACCESS TO KIDNEY TRANSLATION THROUGH PATIENT EXPERIENCES Rachael Walker
0930 – 0945	NEW DATA COLLECTION & CHANGES Kylie Hurst
0945 – 1000	DIALYSIS CAPACITY Eric Au	LUPUS NEPHRITIS IN CHILDREN Alison Ma	SUSTAINABLE KIDNEY CARE: THE UK PERSPECTIVE Suren Kanagasundaram	‘ONE DAY RENAL TRANSPLANT WORKUP’ – A NEW CARE MODEL Scott Crawford
1000 – 1015	DIALYSIS CAPACITY (NZ) Andrew Salmon
1015 – 1030	QUALITY INDICATORS Drew Henderson	PAEDIATRIC NEPHROTIC SYNDROME – TALES FROM DOWNUNDER Chanel Prestidge	WHAT’S A NEPHROLOGIST TO DO ?” Shaundeep Sen	EQUITY AND ACCESS TO TRANSPLANTATION Angela Webster
1030 – 1045	Group Q&A
1045 – 1130	Kai and kōrero \| Morning Tea in the Exhibition \| Exhibition Hall E3
PLENARY #5 \| Auditorium 1 \| Chair: Rathika Krishnasamy
1130 – 1200	Jacquot Fellowships and Awards – Research Establishment \| Prasanti Kotagiri
	Jacquot Fellowships and Awards – Research Entry \| Matthew Sypek
1200 – 1230	Poroaki \| Closing & Handover
1230 – 1330	Kai and kōrero \| Lunch in the Exhibition \| Exhibition Hall E3

2023 ASM Program

ANZSN Annual Scientific Meeting Provisional Program

Rāhina, 4 Mahuru, 2023 | MONDAY 4 September 2023

Rātū 5 Mahuru 2023 | TUESDAY 5 September 2023

Rāapa 6 Mahuru 2023 | WEDNESDAY 6 September 2023

ABOUT THE SOCIETY

ACKNOWLEDGEMENT OF COUNTRY